Financhill
Back

Genpact Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
62

G
Genpact

Last Price:
$55.05
Seasonality Move:
2.83%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Buy
62
Genpact (G) is a Buy

Is Genpact a Buy, Sell or Hold?

  • The current Genpact [G] share price is $55.05. The Score for G is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • G is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

G Stock Price Chart

What is Genpact's stock price today?

  • The Genpact share price today is $55.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and G is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

G Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.78 Buy
Relative Strength Index (14 RSI): 83.19 Buy
Chaikin Money Flow: -260148 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.71 - 52.57) Buy
Bollinger Bands (100): (39.33 - 48.01) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

G Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.56 Buy
20-day SMA: 49.75 Buy
50-day SMA: 46.18 Buy
200-day SMA: 39.06 Buy
8-day EMA: 53.59 Buy
20-day EMA: 50.61 Buy
50-day EMA: 47.23 Buy
200-day EMA: 41.21 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Genpact Earnings Growth & G Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.32 per share, and an increase next year of $0.36 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Genpact Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):